Literature DB >> 8125958

Functional characterization of the INO2 gene of Saccharomyces cerevisiae. A positive regulator of phospholipid biosynthesis.

D M Nikoloff1, S A Henry.   

Abstract

The INO2 locus encodes a novel product showing structural similarity to the basic helix-loop-helix (b-HLH) family of regulatory proteins (Nikoloff, D.M., McGraw, P., and Henry, S.A. (1992) Nucleic Acids Res. 20, 3253). The ino2 mutants exhibit pleiotropic defects in phospholipid metabolism including inability to derepress the biosynthetic enzyme inositol-1-phosphate synthase. Localization of mutations in ino2 strains has demonstrated that the b-HLH domain is required for biological activity and is sensitive to perturbation, thereby establishing a correlation between the structure and function of Ino2p. Defects in the b-HLH domain of Ino2p resulted in reduced DNA binding activity. In addition, the absence of a specific DNA-protein complex correlated with a reduction or loss of INO1 transcription. Studies using Ino2p-specific antibody revealed that Ino2p participates in the formation of specific DNA-protein complexes. Ino2p-dependent binding activity overlapped with a region of the INO1 promoter that contains two potential HLH consensus binding sites. Furthermore, Ino2p showed single base pair discrimination in a putative binding site, establishing a relationship between Ino2p and its target binding site.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125958

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Combinatorial regulation of phospholipid biosynthetic gene expression by the UME6, SIN3 and RPD3 genes.

Authors:  M Elkhaimi; M R Kaadige; D Kamath; J C Jackson; H Biliran; J M Lopes
Journal:  Nucleic Acids Res       Date:  2000-08-15       Impact factor: 16.971

2.  The REG1 gene product is required for repression of INO1 and other inositol-sensitive upstream activating sequence-containing genes of yeast.

Authors:  Q Ouyang; M Ruiz-Noriega; S A Henry
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

3.  Derepression of INO1 transcription requires cooperation between the Ino2p-Ino4p heterodimer and Cbf1p and recruitment of the ISW2 chromatin-remodeling complex.

Authors:  Ameet Shetty; John M Lopes
Journal:  Eukaryot Cell       Date:  2010-10-08

4.  Analysis of Opi1p repressor mutants.

Authors:  Mohan R Kaadige; John M Lopes
Journal:  Curr Genet       Date:  2005-12-02       Impact factor: 3.886

5.  Genome-wide analysis reveals inositol, not choline, as the major effector of Ino2p-Ino4p and unfolded protein response target gene expression in yeast.

Authors:  Stephen A Jesch; Xin Zhao; Martin T Wells; Susan A Henry
Journal:  J Biol Chem       Date:  2004-12-20       Impact factor: 5.157

6.  IN02, a positive regulator of lipid biosynthesis, is essential for the formation of inducible membranes in yeast.

Authors:  Laura Block-Alper; Paul Webster; Xianghong Zhou; Lubica Supeková; Wing Hung Wong; Peter G Schultz; David I Meyer
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

7.  The Snf1 protein kinase and Sit4 protein phosphatase have opposing functions in regulating TATA-binding protein association with the Saccharomyces cerevisiae INO1 promoter.

Authors:  Margaret K Shirra; Sarah E Rogers; Diane E Alexander; Karen M Arndt
Journal:  Genetics       Date:  2005-02-16       Impact factor: 4.562

Review 8.  Genetic regulation of phospholipid biosynthesis in Saccharomyces cerevisiae.

Authors:  M L Greenberg; J M Lopes
Journal:  Microbiol Rev       Date:  1996-03

9.  Genomic analysis of the Opi- phenotype.

Authors:  Leandria C Hancock; Ryan P Behta; John M Lopes
Journal:  Genetics       Date:  2006-04-02       Impact factor: 4.562

10.  INO1-100: an allele of the Saccharomyces cerevisiae INO1 gene that is transcribed without the action of the positive factors encoded by the INO2, INO4, SWI1, SWI2 and SWI3 genes.

Authors:  S Swift; P McGraw
Journal:  Nucleic Acids Res       Date:  1995-04-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.